Multiple companies and nations around the world are racing to develop a vaccine to provide some degree of immunity to the coronavirus, which causes the disease COVID-19. The chief executive of GlaxoSmithKline, the world’s largest maker of vaccines, on Tuesday said she was optimistic the industry will be able to make vaccine widely available next year. Salesforce.com’s efforts build on tools rolled out in May aimed at modifying the company’s business software to help governments make re-opening decisions based on public health data and carry out contact tracing and other tasks related to the pandemic.
